PMID: 25773795Mar 17, 2015Paper

Estimating radiation therapy toxicity and tolerability with comprehensive assessment parameters in geriatric cancer patients

Asian Pacific Journal of Cancer Prevention : APJCP
Sukran UlgerEray Karahacioglu

Abstract

Cancer prevalance and incidence is increasing with aging of populations and age is a critical factor in decision-making for anti-cancer treatment. However it is believed that chronological age is not enough to guide management in elderly cancer patients. Multidisciplinary evaluation and comprehensive geriatric assessment has gained importance regarding the treatment selection especially for definitive anti-cancer therapy recently. We here aimed to analyse the effect of the comprehensive geriatric assessment parameters on radiotherapy toxicity and tolerability in a series of geriatric cancer patients in Turkey.

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jan 1, 1982·Journal of Psychiatric Research·J A YesavageV O Leirer
Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·J D CoxT F Pajak
Jan 1, 1994·Anaesthesia·R J Naylor, F C Inall
Feb 16, 1999·International Journal of Radiation Oncology, Biology, Physics·R Gelman, J R Harris
May 31, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·L Z RubensteinB Vellas
Jun 29, 2005·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Arati V RaoHarvey Jay Cohen
Aug 9, 2005·Critical Reviews in Oncology/hematology·Martine ExtermannUNKNOWN Task Force on CGA of the International Society of Geriatric Oncology
Aug 12, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G FreyerE Pujade-Lauraine
May 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martine Extermann, Arti Hurria
Jun 15, 2007·Annals of the Rheumatic Diseases·Yoav ArnsonYehuda Shoenfeld
Aug 12, 2008·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·C Durdux, C Bauer
Jan 16, 2009·Critical Reviews in Oncology/hematology·Jaime Gomez-Millan
Sep 5, 2009·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·C DurduxM Gisselbrecht
Jul 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sumanta Kumar Pal, Arti Hurria
Aug 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ravindran KanesvaranDonald Poon
Nov 30, 2011·Revue des maladies respiratoires·V AliamusA Vergnenegre
Sep 19, 2012·Seminars in Radiation Oncology·George Rodrigues, Michael Sanatani
May 7, 2013·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·E Le FurC Durdux
Nov 22, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M T E PutsS M H Alibhai
Feb 4, 2014·Journal of Geriatric Oncology·Despina SpyropoulouDimitrios Kardamakis
Mar 20, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Teruo InamotoHirotsugu Uemura
May 13, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Umut VarolRuchan Uslu
Oct 9, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Ebru Sen OranAtilla Soran

❮ Previous
Next ❯

Citations

Feb 2, 2018·BioMed Research International·Sanders ChangKavita V Dharmarajan
Jun 25, 2017·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Rachel LeiferEwa Szumacher
Jun 25, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Nilgun Yilmaz DemirciYurdanur Erdogan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.